ClinVar Miner

Submissions for variant NM_021625.4(TRPV4):c.37G>T (p.Gly13Trp) (rs763302555)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000237063 SCV000292777 uncertain significance not provided 2017-06-22 criteria provided, single submitter clinical testing The G13W variant has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. The G13W variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. However, this substitution occurs at a position that is not conserved across species, and other missense mutations in nearby residues have not been reported in the Human Gene Mutation Database in association with TRPV4-related disorders (Stenson et al., 2014). In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic mutation or a rare benign variant.
Invitae RCV000458201 SCV000549252 uncertain significance Charcot-Marie-Tooth disease type 2C 2018-10-01 criteria provided, single submitter clinical testing This sequence change replaces glycine with tryptophan at codon 13 of the TRPV4 protein (p.Gly13Trp). The glycine residue is weakly conserved and there is a large physicochemical difference between glycine and tryptophan. This variant is present in population databases (rs763302555, ExAC 0.008%). This variant has not been reported in the literature in individuals with TRPV4-related disease. ClinVar contains an entry for this variant (Variation ID: 245716). Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.